Total planned funding: $1,063,223,026
Clear active filters
University
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $184,970,690 |
Kenya | $179,353,364 |
Tanzania | $114,036,229 |
South Africa | $97,246,604 |
Ethiopia | $84,640,651 |
Uganda | $78,879,143 |
Malawi | $42,390,839 |
Nigeria | $36,876,168 |
Zambia | $36,628,380 |
Côte d'Ivoire | $31,761,086 |
Haiti | $22,867,000 |
Botswana | $22,607,730 |
Rwanda | $20,768,956 |
Eswatini | $18,244,522 |
Democratic Republic of the Congo | $14,061,032 |
Namibia | $13,863,881 |
Angola | $11,168,000 |
South Sudan | $9,844,459 |
India | $7,390,217 |
Vietnam | $5,888,735 |
Zimbabwe | $4,993,800 |
Lesotho | $4,767,627 |
Central Asia Region | $4,506,915 |
Caribbean Region | $3,465,000 |
Central America Region | $3,156,907 |
Ukraine | $2,960,000 |
Cameroon | $2,371,572 |
Guyana | $1,043,519 |
Burma | $1,000,000 |
Ghana | $620,000 |
Burundi | $500,000 |
Dominican Republic | $200,000 |
Asia Regional Program | $100,000 |
China | $50,000 |
Organizational Types
University | $1,063,223,026 |
Program Areas
Treatment | $404,454,162 |
Prevention | $210,111,215 |
Governance and Systems | $204,315,913 |
Care | $181,357,914 |
Testing | $62,983,823 |
Budget Codes
HTXS: Treatment: Adult Treatment | $344,277,759 |
HVSI: Strategic Information | $100,510,327 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $91,906,334 |
HBHC: Care: Adult Care and Support | $85,042,642 |
OHSS: Health Systems Strengthening | $78,994,394 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $70,078,557 |
HVCT: Testing: HIV Testing and Counseling | $62,983,823 |
PDTX: Treatment: Pediatric Treatment | $56,052,140 |
HVTB: Care: TB/HIV | $47,933,648 |
HVOP: Sexual Prevention: Other Sexual Prevention | $35,521,143 |
PDCS: Care: Pediatric Care and Support | $26,898,930 |
HLAB: Laboratory Infrastructure | $24,811,192 |
HKID: Care: Orphans and Vulnerable Children | $21,482,694 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,835,465 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $4,549,673 |
HTXD: Treatment: ARV Drugs | $4,124,263 |
HMIN: Biomedical Prevention: Injection Safety | $2,457,619 |
HMBL: Biomedical Prevention: Blood Safety | $762,424 |
Top Partner Programs
Columbia University:
$331,129,636
View countries
Johns Hopkins University:
$155,251,203
View countries
University of Washington:
$109,435,981
View countries
Baylor College of Medicine:
$56,540,197
View countries
Harvard University:
$50,389,638
View countries